Publications by authors named "Jonathan L Gillan"

Article Synopsis
  • Cystic fibrosis (CF) is characterized by heightened neutrophil presence in the airways and inefficient apoptosis, prompting the investigation of whether NETosis (a form of neutrophil clearance) plays a significant role in CF lung disease.
  • In a study involving 45 CF and 15 healthy participants, researchers found higher neutrophil counts and abnormal morphology in CF sputum, alongside elevated levels of inflammatory mediators and NETs, indicating a strong link between NETs and airway inflammation.
  • Treatment with DNase reduced sputum NET levels and mitigated the pro-inflammatory effects of NETs in co-culture experiments, highlighting its potential as an anti-inflammatory therapy in CF management.
View Article and Find Full Text PDF
Article Synopsis
  • Serious end-stage disease manifestations can arise from complications in organs different from the original site of injury or infection, particularly in heart-lung diseases due to their close anatomical relationship.
  • Immune cells and their signaling molecules play a dual role in interorgan communication, effectively relaying messages but also potentially spreading disease.
  • Understanding the interaction between the heart and lung in both healthy and diseased states could lead to new diagnostic methods and improved prevention and treatment options for related health conditions.
View Article and Find Full Text PDF

Respiratory syncytial virus is the major cause of acute lower respiratory tract infections in young children, causing extensive mortality and morbidity globally, with limited therapeutic or preventative options. Cathelicidins are innate immune antimicrobial host defence peptides and have antiviral activity against RSV. However, upper respiratory tract cathelicidin expression and the relationship with host and environment factors in early life, are unknown.

View Article and Find Full Text PDF

An intense, nonresolving airway inflammatory response leads to destructive lung disease in cystic fibrosis (CF). Dysregulation of macrophage immune function may be a key facet governing the progression of CF lung disease, but the underlying mechanisms are not fully understood. We used 5' end centered transcriptome sequencing to profile LPS-activated human CF macrophages, showing that CF and non-CF macrophages deploy substantially distinct transcriptional programs at baseline and following activation.

View Article and Find Full Text PDF

Macrophages represent prominent immune orchestrators of cystic fibrosis (CF) inflammation and, as such, are an ever-increasing focus of CF research with several reports of intrinsic immune dysfunction related to loss of CFTR activity in macrophages themselves. Animal models of CF have contributed, in no small part, to a deepening of our understanding of the pathophysiology of the disease and towards therapeutic development. A commonly-used animal model in CF research is the Cftr Tg(FABP-hCFTR) mouse, which displays gut-specific expression of a human CFTR transgene in order to rescue the high rate of early mortality in Cftr-null mice associated with severe intestinal obstruction.

View Article and Find Full Text PDF

Low density neutrophils (LDNs) are described in a number of inflammatory conditions, cancers and infections and associated with immunopathology, and a mechanistic role in disease. The role of LDNs at homeostasis in healthy individuals has not been investigated. We have developed an isolation protocol that generates high purity LDNs from healthy donors.

View Article and Find Full Text PDF

Cystic fibrosis (CF) is a life-shortening, multi-organ, autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The most prominent clinical manifestation in CF is the development of progressive lung disease characterised by an intense, chronic inflammatory airway response that culminates in respiratory failure and, ultimately, death. In recent years, a new class of therapeutics that have the potential to correct the underlying defect in CF, known as CFTR modulators, have revolutionised the field.

View Article and Find Full Text PDF